Latest Breaking News On - Elizabeth wolffe - Page 1 : comparemela.com

Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of Oncogenic MYB Synthesis, at the American Society of Clinical Oncology Annual Meeting (ASCO 2024)

Rgenta Therapeutics Presents Preclinical Data from Lead Program RGT-61159, a Potent Inhibitor of Oncogenic MYB Synthesis, at the American Society of Clinical Oncology Annual Meeting (ASCO 2024)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Aljanae-reynolds
Elizabeth-wolffe
Sylvia-wheeler
Travis-wager

Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference

Neurona Therapeutics to Participate in Jefferies Global Healthcare Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Coryr-nicholas
Elizabeth-wolffe
Laurence-watts
Marriott-marquis
Neurona-co
Jefferies-global-healthcare
Chief-executive-officer
Jefferies-global-healthcare-conference
Viking-global-investors
Cormorant-asset

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering - Nurix Therapeutics (NASDAQ:NRIX)

SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) Nurix Therapeutics, Inc. (NASDAQ:NRIX) today announced the pricing of its upsized underwritten public offering of 10,166,667 shares of its common stock at a price to

San-francisco
California
United-states
Edgewood
Jason-kantor
Aljanae-reynolds
Elizabeth-wolffe
Piper-sandler-co
Capital-markets
Jp-morgan-securities
Nicolaus-company-incorporated
Prospectus-department

Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering

SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten public offering of 10,166,667 shares of its common stock at a price to the public of $15.00 per share. In addition, and in lieu of common stock, Nurix is offering to certain investors pre-funded warrants to purchase up to an aggregate of 1,500,100 shares of common stock at a purchase price of $14.999 per pre-funded warrant, which represents the per sha

Edgewood
California
United-states
San-francisco
Elizabeth-wolffe
Jason-kantor
Aljanae-reynolds
Nicolaus-company-incorporated
Nurix-therapeutics-inc
Nasdaq
Piper-sandler-co
Broadridge-financial-solutions

Nurix Therapeutics Announces Pricing of Upsized $175.0

SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) Nurix Therapeutics, Inc. (Nasdaq: NRIX) today announced the pricing of its upsized underwritten public.

Edgewood
California
United-states
San-francisco
Elizabeth-wolffe
Aljanae-reynolds
Jason-kantor
Capital-markets
Jp-morgan-securities
Needham-company
Nicolaus-company-incorporated
Nurix-therapeutics-inc